| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra™): Immunogenicity and safety profile
|
Czajka, Hanna
|
|
2009
|
27 |
47 |
p. 6504-6511
8 p.
|
artikel
|
| 2 |
Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-γ and interleukin-12-deficient mice to naive recipients
|
Tessema, Tesfaye Sisay
|
|
2009
|
27 |
47 |
p. 6575-6581
7 p.
|
artikel
|
| 3 |
Corrigendum to “Immunological responses to pneumococcal vaccine in frail older people” [Vaccine 27 (2009) 1628–1636]
|
Ridda, I.
|
|
2009
|
27 |
47 |
p. 6649-
1 p.
|
artikel
|
| 4 |
Cost-effectiveness of pneumococcal conjugate vaccine: An update after 7 years of use in the United States
|
Ray, G. Thomas
|
|
2009
|
27 |
47 |
p. 6483-6494
12 p.
|
artikel
|
| 5 |
CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus
|
Yang, Chunting
|
|
2009
|
27 |
47 |
p. 6558-6563
6 p.
|
artikel
|
| 6 |
Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach
|
Shrivastava, Shubham
|
|
2009
|
27 |
47 |
p. 6582-6588
7 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2009
|
27 |
47 |
p. CO2-
1 p.
|
artikel
|
| 8 |
Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination
|
Liang, Xiaofeng
|
|
2009
|
27 |
47 |
p. 6550-6557
8 p.
|
artikel
|
| 9 |
Estimated research and development costs of rotavirus vaccines
|
Light, Donald W.
|
|
2009
|
27 |
47 |
p. 6627-6633
7 p.
|
artikel
|
| 10 |
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort
|
Irving, Stephanie A.
|
|
2009
|
27 |
47 |
p. 6546-6549
4 p.
|
artikel
|
| 11 |
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months
|
King Jr., James C.
|
|
2009
|
27 |
47 |
p. 6589-6594
6 p.
|
artikel
|
| 12 |
Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan
|
Lu, John Jenn-Yenn
|
|
2009
|
27 |
47 |
p. 6613-6618
6 p.
|
artikel
|
| 13 |
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content
|
Hendrikx, Lotte H.
|
|
2009
|
27 |
47 |
p. 6530-6536
7 p.
|
artikel
|
| 14 |
Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes
|
Gamage, Lakshman N.A.
|
|
2009
|
27 |
47 |
p. 6595-6604
10 p.
|
artikel
|
| 15 |
Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens
|
Center, Rob J.
|
|
2009
|
27 |
47 |
p. 6605-6612
8 p.
|
artikel
|
| 16 |
Leptosome-entrapped leptospiral antigens conferred significant higher levels of protection than those entrapped with PC-liposomes in a hamster model
|
Faisal, Syed M.
|
|
2009
|
27 |
47 |
p. 6537-6545
9 p.
|
artikel
|
| 17 |
Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization
|
Leifer, Immanuel
|
|
2009
|
27 |
47 |
p. 6522-6529
8 p.
|
artikel
|
| 18 |
Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults
|
Valera, Rodrigo
|
|
2009
|
27 |
47 |
p. 6564-6569
6 p.
|
artikel
|
| 19 |
Recombinant Mycobacterium bovis BCG
|
Bastos, Reginaldo G.
|
|
2009
|
27 |
47 |
p. 6495-6503
9 p.
|
artikel
|
| 20 |
Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults
|
Keitel, Wendy A.
|
|
2009
|
27 |
47 |
p. 6642-6648
7 p.
|
artikel
|
| 21 |
Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB®) in target and non-target species
|
Knowles, M. Kimberly
|
|
2009
|
27 |
47 |
p. 6619-6626
8 p.
|
artikel
|
| 22 |
Stimulation of tetanus toxoid-specific immune responses by a traditional Chinese herbal medicine
|
Underwood, John R.
|
|
2009
|
27 |
47 |
p. 6634-6641
8 p.
|
artikel
|
| 23 |
Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice
|
Peng, Gao-Hui
|
|
2009
|
27 |
47 |
p. 6570-6574
5 p.
|
artikel
|
| 24 |
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
|
Price, Graeme E.
|
|
2009
|
27 |
47 |
p. 6512-6521
10 p.
|
artikel
|
| 25 |
What's in a cough? And how can it be prevented
|
Spier, Ray
|
|
2009
|
27 |
47 |
p. 6481-6482
2 p.
|
artikel
|
Tijdschrift beschrijving